An experiment was conducted to determine whether diets based on structural carbohydrate and/or simple sugars, as found in roughage and/or molasses-based diets, reduce the bovine faecal populations of Shiga toxin-producing Escherichia coli (STEC) isolates containing the eaeA and ehxA genes, referred to as complex STEC (cSTEC), compared with typical high starch, grain-based feedlot diets. In addition, whether commercial lairage management practices promote or diminish any diet-induced responses on the contamination of carcasses was also investigated. After 13 days on the dietary treatments total faecal E. coli numbers were approximately one log lower in the roughage (R) and roughage +50% molasses (RM) diets compared with grain (G) fed animals, this difference varying between 0.5 and 1 log at lairage. Fermentation patterns were similar in the R and RM diets whereas decreased pH and enhanced butyrate fermentation pathways were associated with the G diet. A significant decrease in the faecal concentration of the eaeA gene occurred when animals were changed from high grain to R and RM diets for 6-13 days, compared with animals maintained on the G diet. Significantly lower concentrations of the ehxA gene were also associated with the R diet. Concentrations of the stx(2) gene however, were unaffected by diet. cSTEC were infrequently isolated, with the faecal concentrations of these organisms being low (<3 log(10) MPN per g faeces). cSTEC were only isolated from animals fed G or RM diets, but were never isolated from cattle fed the roughage-based diet, with this diet-induced effect sustained following lairage. These organisms were not detected on the hide and carcass of animals found to shed cSTEC in their faeces and thus appeared uncontaminated with cSTEC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijfoodmicro.2007.11.019 | DOI Listing |
Microorganisms
January 2025
Department of Food Science and Biotechnology, College of Bionano Technology, Gachon University, Seongnam 13120, Republic of Korea.
Shiga toxin-producing (STEC) infections have increased in humans, animals, and the food industry, with ready-to-eat (RTE) food products being particularly susceptible to contamination. The prevalence of multidrug-resistant strains has rendered the current control strategies insufficient to effectively control STEC infections. Herein, we characterized the newly isolated STEC phage vB_ESM-pEJ01, a polyvalent phage capable of infecting and species, and assessed its efficacy in reducing STEC in vitro and food matrices.
View Article and Find Full Text PDFJ Med Microbiol
January 2025
NIHR Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool, UK.
Diarrhoeagenic (DEC) pathotypes are defined by genes located on mobile genetic elements, and more than one definitive pathogenicity gene may be present in the same strain. In August 2022, UK Health Security Agency (UKHSA) surveillance systems detected an outbreak of hybrid Shiga toxin-producing /enterotoxigenic (STEC-ETEC) serotype O101:H33 harbouring both Shiga toxin () and heat-stable toxin (). These hybrid strains of DEC are a public health concern, as they are often associated with enhanced pathogenicity.
View Article and Find Full Text PDFEpidemiol Infect
January 2025
Gastrointestinal Infections and Food Safety (One Health) Division, Clinical and Public Health Group, UK Health Security Agency, London, UK.
In July 2022, a genetically linked and geographically dispersed cluster of 12 cases of Shiga toxin-producing (STEC) O103:H2 was detected by the UK Health Security Agency using whole genome sequencing. Review of food history questionnaires identified cheese (particularly an unpasteurized brie-style cheese) and mixed salad leaves as potential vehicles. A case-control study was conducted to investigate exposure to these products.
View Article and Find Full Text PDFJ Infect Dis
January 2025
Division of Environmental Health Sciences, School of Public Health, University of Minnesota, St. Paul, MN 55108, USA.
Shiga toxin-producing Escherichia coli (STEC) infections pose a significant public health challenge, characterized by severe complications including hemolytic uremic syndrome (HUS) due to Shiga toxin (Stx) production. Current therapeutic approaches encounter a critical limitation, as conventional antibiotic treatment is contraindicated due to its propensity to trigger bacterial SOS response and subsequently enhance Stx production, which increases the likelihood of developing HUS in antibiotic-treated patients. The lack of effective, safe therapeutic options has created an urgent need for alternative treatment strategies for STEC infections.
View Article and Find Full Text PDFJ Infect Dis
January 2025
Dept Microbiol., Immunol., Infect. Dis., Cumming School of Medicine, University of Calgary.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!